FDA asks Hyland’s teething tablets maker to recall medicines containing belladonna

FDA found that certain teething tablets for children sometimes exceed the amount of belladonna – a toxic  substance – and has asked the company that makes them to recall such medicine.

The US Food and Drug Administration issued a warning to users of teething products that have belladonna are risk-bearing addition to chilren and infants, which should not be used.

Standard Homeopathic Company from LA that produces Hyland’s teething tablets has been particularly asked to recall its homeopathic tablets labeled to contain belladonna to protect users. The FDA said that the company hasn’t agreed yet to recall its product.

FDA said it never evaluated or approved homeopathic teething products for safety or effectiveness. “The agency is unaware of any proven health benefit of the products, which are labeled to relieve teething symptoms in children. In September 2016, the FDA warned against the use of these products after receiving adverse event reports,” the food and drug governing body said.

In November 2016, New Jersey-based Raritan Pharmaceuticals recalled three belladonna-containing homeopathic products, two of which were marketed by CVS.

The FDA recommends that consumers stop using these products marketed by Hyland’s immediately, and dispose of any in their possession.